Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/OCUGEN-INC-19157135/news/Ocugen-Inc-Announces-First-Patient-Dosed-in-Phase-1-2-Clinical-Trial-for-Gene-Therapy-Candidate-OC-39936013/?utm_source=whatsapp&utm_medium=social&utm_campaign=share